Authors:
ERIKSEN EF
LANGDAHL B
GLERUP H
VESTERBY A
RUNGBY J
KASSEM M
Citation: Ef. Eriksen et al., HORMONE REPLACEMENT THERAPY (HRT) PRESERVES BONE BALANCE BY PREVENTING OSTEOCLASTIC HYPERACTIVITY IN POSTMENOPAUSAL WOMEN - A RANDOMIZED, PROSPECTIVE, HISTOMORPHOMETRIC STUDY, Journal of bone and mineral research, 11, 1996, pp. 597-597
Authors:
RIX M
OLGAARD K
ANDREASSEN H
LANGDAHL B
ESKILDSEN P
Citation: M. Rix et al., LOW BONE-MINERAL DENSITY IN PATIENTS WITH MILD-TO-MODERATE RENAL-FAILURE, Journal of bone and mineral research, 11, 1996, pp. 764-764
Citation: Ef. Eriksen et al., GROWTH-HORMONE, INSULIN-LIKE GROWTH-FACTORS AND BONE REMODELING, European journal of clinical investigation, 26(7), 1996, pp. 525-534
Authors:
LANGDAHL B
ERIKSEN EF
MORTENSEN L
CHARLES P
BEKKER P
AXELROD D
Citation: B. Langdahl et al., HISTOMORPHOMETRY FROM A 3-YEAR RISEDRONATE BONE LOSS PREVENTION STUDY, Journal of bone and mineral research, 10, 1995, pp. 199-199
Authors:
HAUGE EM
STEINICHE T
BROCKSTEDT H
LANGDAHL B
MOSEKILDE L
MELSEN F
Citation: Em. Hauge et al., A HISTOMORPHOMETRIC COMPARISON OF GLUCOCORTICOID-INDUCED AND PRIMARY OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 289-289
Authors:
HAUGE EM
STEINICHE T
BROCKSTEDT H
LANGDAHL B
MELSEN F
Citation: Em. Hauge et al., A COMPARATIVE-STUDY OF PRIMARY OSTEOPOROSIS AND OSTEOPOROSIS SECONDARY TO GLUCOCORTICOIDS, Calcified tissue international, 54(4), 1994, pp. 351-351
Citation: L. Mortensen et al., REVERSIBLE INHIBITION OF HIGH BONE TURNOVER BY RISEDRONATE - A DOSE-DEPENDENT EFFECT, Journal of bone and mineral research, 8, 1993, pp. 190000231-190000231